DXCM vs ABT: Which Stock is Better?
Side-by-side comparison of DexCom Inc and Abbott Laboratories in 2026
DXCM
DexCom Inc
—
ABT
Abbott Laboratories
$93.93
Key Metrics Comparison
| Metric | DXCM | ABT | Winner |
|---|---|---|---|
| Market Cap | $32.84B | $154.15B | ABT |
| P/E Ratio | 62.51 | 24.79 | ABT |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze DXCM
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is DXCM or ABT a better investment?
Comparing DXCM and ABT: DexCom Inc has a market cap of $32.84B while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between DXCM and ABT?
DXCM (DexCom Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: DXCM or ABT?
Based on P/E ratios, ABT trades at a lower multiple (24.8x vs 62.5x).
Which is growing faster: DXCM or ABT?
Both DXCM and ABT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: DXCM or ABT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: DXCM or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $32.84B for DXCM.
Should I buy DXCM or ABT in 2026?
Both DXCM and ABT have investment merit. DXCM trades at $N/A while ABT trades at $93.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between DXCM and ABT stock?
Key differences: Market Cap ($32.84B vs $154.15B), P/E Ratio (62.5x vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy DXCM or ABT in 2026?
The choice between DXCM and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between DXCM and ABT?
DXCM (DexCom Inc) has a market cap of $32.84B, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.